Published • loading... • Updated
Ozempic Can Reduce the Risk of Breast Cancer, Says Study
Summary by A TARDE
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A new research investigates the possibility of the Ozempic reducing the risk of breast cancer. The study, conducted by researchers from the University of Pennsylvania, was presented during an annual meeting of the American Society of Clinical Oncology (ASCO). As a result, the study showed that women who used the GLP-1 class drug presented between 30% and 35% less chances of developing breast cancer than those who did not use the medication.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
